ArticleFrontiers in molecular biosciences2026
Mechanisms driving open-closed transitions and dimer stability of the large GTPases hGBP1 and hGBP5.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human guanylate-binding proteins 1 and 5 (hGBP1/5) are key players in innate immunity, vital for defending against intracellular pathogens and mediating membrane-associated immune responses. These protein functions are closely linked to their structural dynamics, making a detailed understanding of the conformational behavior imperative. The closed conformation of hGBP1 is well-characterized through crystallography, but the structural basis for its transition to an active, open state remains less understood. This study uses all-atom and coarse-grained molecular dynamics simulations to investigate the stability and motions of extended monomeric and dimeric hGBP1 and hGBP5 with and without GTP bound. Results reveal that dimers exhibit greater stability than monomers, primarily due to extensive stalk interactions that facilitate a structural crossing of the protomers at the interface of the GTPase and middle domains. This arrangement aligns the middle and effector domains parallel to one another, further stabilizing the dimeric state through the formation of coiled-coil structures supported by salt bridges and hydrophobic contacts. Notably, monomers of both hGBP1 and hGBP5 can revert to a closed state stabilized by a network of salt bridges between the effector domain and the surrounding domains. In hGBP5, this transition is further facilitated by the geranylgeranyl group, which more effectively reaches and buries itself within a hydrophobic pocket of the GTPase domain compared to hGBP1. These findings highlight key factors affecting the stability of hGBP1/5 monomers and dimers, providing insights into their activation mechanisms that are relevant for their role in innate immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.